Moclobemide: a reversible inhibitor of monoamine oxidase type A
Affiliations
- PMID: 8490690
Item in Clipboard
Moclobemide: a reversible inhibitor of monoamine oxidase type A
Br J Hosp Med.
1993 Apr.
Abstract
The search for the ideal antidepressant continues. Moclobemide, the first reversible inhibitor of monoamine oxidase type A to enter widespread clinical use, has a number of advantages over traditional monoamine oxidase inhibitors and represents a valuable addition to the antidepressant armamentarium.
Similar articles
-
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].Nervenarzt. 1996 May;67(5):339-47. Nervenarzt. 1996. PMID: 9005342 Review. German.
-
Studies of selective and reversible monoamine oxidase inhibitors.J Clin Psychiatry. 1984 Jul;45(7 Pt 2):62-6. J Clin Psychiatry. 1984. PMID: 6429130 Clinical Trial.
-
RIMA: a safe concept in the treatment of depression with moclobemide.Can J Psychiatry. 1992 Sep;37 Suppl 1:7-11. Can J Psychiatry. 1992. PMID: 1394030 Review.
-
Depression: advances in drug treatment.Nurs Stand. 1993 Nov 24-30;8(10):36. Nurs Stand. 1993. PMID: 8297750 No abstract available.
-
Moclobemide for depression.Drug Ther Bull. 1994 Jan 20;32(1):6-8. Drug Ther Bull. 1994. PMID: 7635005